{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,27]],"date-time":"2025-07-27T07:19:33Z","timestamp":1753600773130,"version":"3.37.3"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s13300-023-01487-1","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T09:02:48Z","timestamp":1698915768000},"page":"165-181","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Midnight Cortisol is Associated with Changes in Systolic Blood Pressure and Diabetic Neuropathy in Subjects with Type\u00a01 Diabetes Undergoing Simultaneous Kidney-Pancreas Transplantation"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8553-4030","authenticated-orcid":false,"given":"Laura","family":"Boswell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio J.","family":"Amor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Montagud-Marrahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregori","family":"Casals","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"D\u00edaz-Catalan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisenda","family":"Banon-Maneus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Ram\u00edrez-Bajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Hierro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fritz","family":"Diekmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mireia","family":"Musquera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tonet","family":"Ser\u00e9s-Noriega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enric","family":"Esmatjes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Ferrer-F\u00e0brega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0119-1331","authenticated-orcid":false,"given":"Pedro","family":"Ventura-Aguiar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2399-4023","authenticated-orcid":false,"given":"Felicia A.","family":"Hanzu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,2]]},"reference":[{"key":"1487_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s2213-8587(21)00172-8","volume":"8587","author":"V Harjutsalo","year":"2021","unstructured":"Harjutsalo V, Pongrac Barlovic D, Groop P-H. Long-term population-based trends in the incidence of cardiovascular disease in individuals with type\u00a01 diabetes from Finland: a retrospective, nationwide, cohort study. Lancet Diabetes Endocrinol. 2021;8587:1\u201311. https:\/\/doi.org\/10.1016\/s2213-8587(21)00172-8.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1487_CR2","doi-asserted-by":"publisher","unstructured":"GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1459\u2013544. https:\/\/doi.org\/10.1016\/S0140-6736(16)31012-1.","DOI":"10.1016\/S0140-6736(16)31012-1"},{"key":"1487_CR3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1053\/j.ackd.2014.03.003","volume":"21","author":"R P\u00e1lsson","year":"2014","unstructured":"P\u00e1lsson R, Patel UD. Cardiovascular complications of diabetic kidney disease. Adv Chronic Kidney Dis. 2014;21:273\u201380. https:\/\/doi.org\/10.1053\/j.ackd.2014.03.003.","journal-title":"Adv Chronic Kidney Dis"},{"key":"1487_CR4","doi-asserted-by":"crossref","unstructured":"Fridell JA, Stratta RJ, Gruessner AC. Pancreas transplantation: current challenges, considerations, and controversies. J Clin Endocrinol Metab. 2023;108(3):614\u201323.","DOI":"10.1210\/clinem\/dgac644"},{"key":"1487_CR5","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000003710","author":"E Montagud-marrahi","year":"2021","unstructured":"Montagud-Marrahi E, Molina-And\u00fajar A, Pan\u00e9 A, et al. Impact of simultaneous pancreas-kidney transplantation on cardiovascular risk in patients with diabetes. Transplantation. 2021. https:\/\/doi.org\/10.1097\/TP.0000000000003710.","journal-title":"Transplantation"},{"key":"1487_CR6","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s00109-021-02076-0","volume":"99","author":"A Vega-Beyhart","year":"2021","unstructured":"Vega-Beyhart A, Iruarrizaga M, Pan\u00e9 A, et al. Endogenous cortisol excess confers a unique lipid signature and metabolic network. J Mol Med. 2021;99:1085\u201399. https:\/\/doi.org\/10.1007\/s00109-021-02076-0.","journal-title":"J Mol Med"},{"key":"1487_CR7","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/cen.13023","volume":"85","author":"EM de Luj\u00e1n Cardoso","year":"2016","unstructured":"de Luj\u00e1n Cardoso EM, Arregger AL, Budd D, Zucchini AE, Contreras LN. Dynamics of salivary cortisol in chronic kidney disease patients at stages 1 through 4. Clin Endocrinol (Oxf). 2016;85:313\u20139. https:\/\/doi.org\/10.1111\/cen.13023.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1487_CR8","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1210\/jcem-50-1-46","volume":"50","author":"EZ Wallace","year":"1980","unstructured":"Wallace EZ, Rosman P, Toshav N, Sacerdote A, Balthazar A. Pituitary-adrenocortical function in chronic renal failure: studies of episodic secretion of cortisol and dexamethasone suppressibility. J Clin Endocrinol Metab. 1980;50:46\u201351. https:\/\/doi.org\/10.1210\/jcem-50-1-46.","journal-title":"J Clin Endocrinol Metab"},{"key":"1487_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1530\/ec-12-0058","volume":"2","author":"H Raff","year":"2012","unstructured":"Raff H, Trivedi H. Circadian rhythm of salivary cortisol, plasma cortisol, and plasma ACTH in end-stage renal disease. Endocr Connect. 2012;2:23\u201331. https:\/\/doi.org\/10.1530\/ec-12-0058.","journal-title":"Endocr Connect"},{"key":"1487_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1507\/endocrj.EJ15-0360","volume":"63","author":"T Asao","year":"2016","unstructured":"Asao T, Oki K, Yoneda M, Tanaka J, Kohno N. Hypothalamic-pituitary-adrenal axis activity is associated with the prevalence of chronic kidney disease in diabetic patients. Endocr J. 2016;63:119\u201326. https:\/\/doi.org\/10.1507\/endocrj.EJ15-0360.","journal-title":"Endocr J"},{"key":"1487_CR11","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1210\/JS.2018-00088","volume":"2","author":"CM Gant","year":"2018","unstructured":"Gant CM, Minovic I, Binnenmars H, et al. Lower renal function is associated with derangement of 11-\u03b2 hydroxysteroid dehydrogenase in type\u00a02 diabetes. J Endocr Soc. 2018;2:609\u201320. https:\/\/doi.org\/10.1210\/JS.2018-00088.","journal-title":"J Endocr Soc"},{"key":"1487_CR12","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/cen.13889","volume":"90","author":"MS Sagmeister","year":"2019","unstructured":"Sagmeister MS, Taylor AE, Fenton A, et al. Glucocorticoid activation by 11\u03b2-hydroxysteroid dehydrogenase enzymes in relation to inflammation and glycaemic control in chronic kidney disease: a cross-sectional study. Clin Endocrinol (Oxf). 2019;90:241\u20139. https:\/\/doi.org\/10.1111\/cen.13889.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1487_CR13","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1530\/EC-19-0407","volume":"8","author":"EO Melin","year":"2019","unstructured":"Melin EO, Hillman M, Landin-Olsson M. Midnight salivary cortisol secretion associated with high systolic blood pressure in type\u00a01 diabetes. Endocr Connect. 2019;8:1520\u20138. https:\/\/doi.org\/10.1530\/EC-19-0407.","journal-title":"Endocr Connect"},{"key":"1487_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13098-019-0481-3","volume":"11","author":"EO Melin","year":"2019","unstructured":"Melin EO, Hillman M, Thunander M, Landin-Olsson M. Midnight salivary cortisol secretion and the use of antidepressants were associated with abdominal obesity in women with type\u00a01 diabetes: a cross sectional study. Diabetol Metab Syndr. 2019;11:1\u201312. https:\/\/doi.org\/10.1186\/s13098-019-0481-3.","journal-title":"Diabetol Metab Syndr"},{"key":"1487_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1472-6823-14-75","volume":"14","author":"EO Melin","year":"2014","unstructured":"Melin EO, Thunander M, Landin-Olsson M, Hillman M, Thulesius HO. Depression, smoking, physical inactivity and season independently associated with midnight salivary cortisol in type\u00a01 diabetes. BMC Endocr Disord. 2014;14:75. https:\/\/doi.org\/10.1186\/1472-6823-14-75.","journal-title":"BMC Endocr Disord"},{"key":"1487_CR16","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/pedi.12108","volume":"15","author":"AN Sharma","year":"2014","unstructured":"Sharma AN, Wigham J, Veldhuis JD. Corticotropic axis drive of overnight cortisol secretion is suppressed in adolescents and young adults with type\u00a01 diabetes mellitus. Pediatr Diabetes. 2014;15:444\u201352. https:\/\/doi.org\/10.1111\/pedi.12108.","journal-title":"Pediatr Diabetes"},{"key":"1487_CR17","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.steroids.2006.02.005","volume":"71","author":"T Remer","year":"2006","unstructured":"Remer T, Maser-Gluth C, Boye KR, Hartmann MF, Heinze E, Wudy SA. Exaggerated adrenarche and altered cortisol metabolism in type\u00a01 diabetic children. Steroids. 2006;71:591\u20138. https:\/\/doi.org\/10.1016\/j.steroids.2006.02.005.","journal-title":"Steroids"},{"key":"1487_CR18","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.mce.2018.01.021","volume":"473","author":"S Christakoudi","year":"2018","unstructured":"Christakoudi S, Runglall M, Mobillo P, et al. Steroid regulation: an overlooked aspect of tolerance and chronic rejection in kidney transplantation. Mol Cell Endocrinol. 2018;473:205\u201316. https:\/\/doi.org\/10.1016\/j.mce.2018.01.021.","journal-title":"Mol Cell Endocrinol"},{"key":"1487_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.steroids.2017.09.001","volume":"127","author":"LV De Vries","year":"2017","unstructured":"De Vries LV, De Jong WHA, Touw DJ, et al. Twenty-four hour urinary cortisol excretion and the metabolic syndrome in prednisolone-treated renal transplant recipients. Steroids. 2017;127:31\u20139. https:\/\/doi.org\/10.1016\/j.steroids.2017.09.001.","journal-title":"Steroids"},{"key":"1487_CR20","first-page":"110","volume":"8","author":"H Eskandari Naji","year":"2017","unstructured":"Eskandari Naji H, Ghorbanihaghjo A, Argani H, et al. Serum sTWEAK and FGF-23 levels in hemodialysis and renal transplant patients. Int J Organ Transplant Med. 2017;8:110\u20136.","journal-title":"Int J Organ Transplant Med"},{"key":"1487_CR21","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.atherosclerosis.2017.03.043","volume":"260","author":"V Fern\u00e1ndez-Laso","year":"2017","unstructured":"Fern\u00e1ndez-Laso V, M\u00e9ndez-Barbero N, Valdivielso JM, et al. Soluble TWEAK and atheromatosis progression in patients with chronic kidney disease. Atherosclerosis. 2017;260:130\u20137. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.03.043.","journal-title":"Atherosclerosis"},{"key":"1487_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.atherosclerosis.2018.01.011","volume":"270","author":"M Bozic","year":"2018","unstructured":"Bozic M, M\u00e9ndez-Barbero N, Guti\u00e9rrez-Mu\u00f1oz C, et al. Combination of biomarkers of vascular calcification and sTWEAK to predict cardiovascular events in chronic kidney disease. Atherosclerosis. 2018;270:13\u201320. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.01.011.","journal-title":"Atherosclerosis"},{"key":"1487_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043919","volume":"7","author":"G Llaurad\u00f3","year":"2012","unstructured":"Llaurad\u00f3 G, Gonz\u00e1lez-Clemente J-M, Maym\u00f3-Masip E, Sub\u00edas D, Vendrell J, Chac\u00f3n MR. Serum levels of TWEAK and scavenger receptor CD163 in type\u00a01 diabetes mellitus: relationship with cardiovascular risk factors. A case\u2013control study. PLoS\u00a0One. 2012;7:e43919. https:\/\/doi.org\/10.1371\/journal.pone.0043919.","journal-title":"PLoS\u00a0One"},{"key":"1487_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109026","volume":"179","author":"AJ Amor","year":"2021","unstructured":"Amor AJ, Casas A, Pan\u00e9 A, et al. Weight gain following pancreas transplantation in type\u00a01 diabetes is associated with a worse glycemic profile: a retrospective cohort study. Diabetes Res Clin Pract. 2021;179:109026. https:\/\/doi.org\/10.1016\/j.diabres.2021.109026.","journal-title":"Diabetes Res Clin Pract"},{"issue":"39","key":"1487_CR25","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"2018","author":"V Aboyans","year":"2017","unstructured":"Aboyans V, Ricco J-B, Bartelink M-LEL, et al. ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries endorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2017;2018(39):763\u2013816. https:\/\/doi.org\/10.1093\/eurheartj\/ehx095.","journal-title":"Eur Heart J"},{"issue":"39","key":"1487_CR26","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"2018","author":"V Aboyans","year":"2017","unstructured":"Aboyans V, Ricco J-B, Bartelink M-LEL, et al. ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur Heart J. 2017;2018(39):763\u2013816. https:\/\/doi.org\/10.1093\/eurheartj\/ehx095.","journal-title":"Eur Heart J"},{"key":"1487_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108135","author":"S Ruiz","year":"2020","unstructured":"Ruiz S, Amor AJ, Pan\u00e9 A, et al. Cardiovascular risk factors and cardiovascular disease in patients with type\u00a01 diabetes and end-stage renal disease candidates for kidney-pancreas transplantation: trends from 1999 to 2017. Diabetes Res Clin Pract. 2020. https:\/\/doi.org\/10.1016\/j.diabres.2020.108135.","journal-title":"Diabetes Res Clin Pract"},{"key":"1487_CR28","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/TP.0000000000003710","volume":"106","author":"E Montagud-Marrahi","year":"2022","unstructured":"Montagud-Marrahi E, Molina-And\u00fajar A, Pan\u00e9 A, et al. Impact of simultaneous pancreas-kidney transplantation on cardiovascular risk in patients with diabetes. Transplantation. 2022;106:158\u201366. https:\/\/doi.org\/10.1097\/TP.0000000000003710.","journal-title":"Transplantation"},{"key":"1487_CR29","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1159\/000443435","volume":"41","author":"X Li","year":"2016","unstructured":"Li X, Xiang X, Hu J, et al. Association between serum cortisol and chronic kidney disease in patients with essential hypertension. Kidney Blood Press Res. 2016;41:384\u201391. https:\/\/doi.org\/10.1159\/000443435.","journal-title":"Kidney Blood Press Res"},{"key":"1487_CR30","doi-asserted-by":"publisher","first-page":"3622","DOI":"10.1210\/jc.2012-1411","volume":"97","author":"A Mongia","year":"2012","unstructured":"Mongia A, Vecker R, George M, et al. Role of 11\u03b2HSD type\u00a02 enzyme activity in essential hypertension and children with chronic kidney disease (CKD). J Clin Endocrinol Metab. 2012;97:3622\u20139. https:\/\/doi.org\/10.1210\/jc.2012-1411.","journal-title":"J Clin Endocrinol Metab"},{"key":"1487_CR31","doi-asserted-by":"publisher","first-page":"247","DOI":"10.5414\/cn108311","volume":"82","author":"C Gracia-Iguacel","year":"2014","unstructured":"Gracia-Iguacel C, Gonz\u00e1lez-Parra E, Egido J, et al. Cortisol levels are associated with mortality risk in hemodialysis patients. Clin Nephrol. 2014;82:247\u201356. https:\/\/doi.org\/10.5414\/cn108311.","journal-title":"Clin Nephrol"},{"key":"1487_CR32","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12882-022-02722-w","volume":"23","author":"J Kim","year":"2022","unstructured":"Kim J, Yun K-S, Cho A, et al. High cortisol levels are associated with oxidative stress and mortality in maintenance hemodialysis patients. BMC Nephrol. 2022;23:98. https:\/\/doi.org\/10.1186\/s12882-022-02722-w.","journal-title":"BMC Nephrol"},{"key":"1487_CR33","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2337\/diab.29.4.257","volume":"29","author":"J Hilsted","year":"1980","unstructured":"Hilsted J, Galbo H, Christensen NJ. Impaired responses of catecholamines, growth hormone, and cortisol to graded exercise in diabetic autonomic neuropathy. Diabetes. 1980;29:257\u201362. https:\/\/doi.org\/10.2337\/diab.29.4.257.","journal-title":"Diabetes"},{"key":"1487_CR34","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.2337\/diacare.21.11.1960","volume":"21","author":"C Meyer","year":"1998","unstructured":"Meyer C, Grossmann R, Mitrakou A, et al. Effects of autonomic neuropathy on counterregulation and awareness of hypoglycemia in type\u00a01 diabetic patients. Diabetes Care. 1998;21:1960\u20136. https:\/\/doi.org\/10.2337\/diacare.21.11.1960.","journal-title":"Diabetes Care"},{"key":"1487_CR35","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1002\/(SICI)1096-9136(199611)13:11<983::AID-DIA271>3.0.CO;2-7","volume":"13","author":"A Dejgaard","year":"1996","unstructured":"Dejgaard A, Andersen P, Hvidberg A, Hilsted J. Cardiovascular, metabolic, and hormonal responses to noradrenaline in diabetic patients with autonomic neuropathy. Diabet Med. 1996;13:983\u20139. https:\/\/doi.org\/10.1002\/(SICI)1096-9136(199611)13:11%3c983::AID-DIA271%3e3.0.CO;2-7.","journal-title":"Diabet Med"},{"key":"1487_CR36","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1210\/jcem.76.3.8383141","volume":"76","author":"C Tsigos","year":"1993","unstructured":"Tsigos C, Young RJ, White A. Diabetic neuropathy is associated with increased activity of the hypothalamic-pituitary-adrenal axis. J Clin Endocrinol Metab. 1993;76:554\u20138. https:\/\/doi.org\/10.1210\/jcem.76.3.8383141.","journal-title":"J Clin Endocrinol Metab"},{"key":"1487_CR37","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/TP.0000000000004275","volume":"107","author":"L Boswell","year":"2023","unstructured":"Boswell L, Ventura-Aguiar P, Alejaldre A, et al. Diabetic neuropathy is independently associated with worse graft outcomes and incident cardiovascular disease after pancreas transplantation: a retrospective cohort study in type\u00a01 diabetes. Transplantation. 2023;107:475\u201384. https:\/\/doi.org\/10.1097\/TP.0000000000004275.","journal-title":"Transplantation"},{"key":"1487_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fimmu.2014.00003","volume":"5","author":"LM Blanco-Colio","year":"2014","unstructured":"Blanco-Colio LM. TWEAK\/Fn14 axis: a promising target for the treatment of cardiovascular diseases. Front Immunol. 2014;5:3. https:\/\/doi.org\/10.3389\/fimmu.2014.00003.","journal-title":"Front Immunol"},{"key":"1487_CR39","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.5301\/jn.5000245","volume":"26","author":"JM Valdivielso","year":"2013","unstructured":"Valdivielso JM, Coll B, Mart\u00edn-Ventura JL, et al. Soluble TWEAK is associated with atherosclerotic burden in patients with chronic kidney disease. J Nephrol. 2013;26:1105\u201313. https:\/\/doi.org\/10.5301\/jn.5000245.","journal-title":"J Nephrol"},{"key":"1487_CR40","first-page":"27","volume":"5","author":"SB Hassan","year":"2012","unstructured":"Hassan SB, El-demery AB, Ahmed AI, Abukhalil RE. Soluble TWEAK and cardiovascular morbidity and mortality in chronic kidney disease patients. Arab J Nephrol Transplant. 2012;5:27\u201332.","journal-title":"Arab J Nephrol Transplant"},{"key":"1487_CR41","first-page":"335","volume":"46","author":"RE McCabe","year":"1980","unstructured":"McCabe RE, Lattes CG, Lorieo DR, Hashim GA, Fitzpatrick HF. The protective effect of methyl prednisolone on the machine-preserved kidney. Am Surg. 1980;46:335\u20139.","journal-title":"Am Surg"},{"key":"1487_CR42","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1182\/blood-2015-01-620583","volume":"126","author":"M Chopra","year":"2015","unstructured":"Chopra M, Brandl A, Siegmund D, et al. Blocking TWEAK-Fn14 interaction inhibits hematopoietic stem cell transplantation-induced intestinal cell death and reduces GVHD. Blood. 2015;126:437\u201344. https:\/\/doi.org\/10.1182\/blood-2015-01-620583.","journal-title":"Blood"},{"key":"1487_CR43","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1111\/eci.12166","volume":"43","author":"MI Yilmaz","year":"2013","unstructured":"Yilmaz MI, Sonmez A, Saglam M, et al. Soluble TWEAK plasma levels increase after renal transplantation and associate with the improvement of endothelial function. Eur J Clin Investig. 2013;43:1250\u20137. https:\/\/doi.org\/10.1111\/eci.12166.","journal-title":"Eur J Clin Investig"},{"key":"1487_CR44","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1111\/ajt.14632","volume":"18","author":"M Claus","year":"2018","unstructured":"Claus M, Herro R, Wolf D, et al. The TWEAK\/Fn14 pathway is required for calcineurin inhibitor toxicity of the kidneys. Am J Transplant. 2018;18:1636\u201345. https:\/\/doi.org\/10.1111\/ajt.14632.","journal-title":"Am J Transplant"}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-023-01487-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13300-023-01487-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-023-01487-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T03:41:27Z","timestamp":1705117287000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13300-023-01487-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,2]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["1487"],"URL":"https:\/\/doi.org\/10.1007\/s13300-023-01487-1","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"type":"print","value":"1869-6953"},{"type":"electronic","value":"1869-6961"}],"subject":[],"published":{"date-parts":[[2023,11,2]]},"assertion":[{"value":"28 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Laura Boswell, Antonio J Amor, Enrique Montagud-Marrahi, Gergori Casals, Daniela Dias-Catalan, Elisenda Banon-Maneus, Maria Jose Ramirez-Bajo, Natalia Hierro, Fritz Diekmann, Mireia, Musquera, Tonet Seres-Noriega, Enric Esmatjes, Joana Ferrer-Fabrega, Pedro Ventura-Aguiar, and Felicia A Hanzu have no competing interests. Laura Boswell received a research grant (Resident Award \u201cPremi Fi de Resid\u00e8nica Emili Letang\u201d 2019) from Hospital Cl\u00ednic de Barcelona, Research, Innovation and Education Department and a research grant (\u201cAjut\u00a0ACD\u00a0per la realitzaci\u00f3 del programa de doctorat 2020\u201d) from Associaci\u00f3 Catalana de Diabetis (ACD).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study protocol was conducted in accordance with the Declaration of Helsinki of 1964 and its later amendments and approved by the Hospital Cl\u00ednic de Barcelona Research Ethics Committee (reference number HCB\/2016\/0479). All subjects provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}